Procurement Summary
Country : Slovakia
Summary : Burosumab
Deadline : 09 Oct 2023
Other Information
Notice Type : Tender
TOT Ref.No.: 88736619
Document Ref. No. : 549674-2023
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 985177.20
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of the order is a medicine with the active substance burosumab, known as Crysvita (hereinafter only the product), for pediatric patients with x-linked form of hypophosphatemic rickets, when all the criteria listed below are met:
1) with a documented high serum concentration of FGF-23
2) with genetically confirmed to himtation in the PHEx gene
3) persistence of low hypophosphatemia despite long-term substitution with maximum tolerated doses of phosphate solution and active form of vitamin D
4) in progression of bone deformities despite administration of maximum tolerated doses of standard treatment (phosphates and vitamin D).
Doc Title: Medicinal products for the musculo-skeletal system
Contract Type: Supplies
Document Type : Contract notice
Reference Number : 27-VO/2023/RDFN
Contract Type : Supplies
Estimated Value : 985177.20 - EUR
33632000 - Medicinal products for the musculo-skeletal system
60000000 - Transport services (excl. Waste transport)
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Medicinal products for the musculo-skeletal system
Dispatch Date : 2023-09-07
Publish Date : 2023-09-12
Submission Date : 2023-10-09
Documents
Tender Notice